Results 201 to 210 of about 2,897 (211)

The Case for Physiologically Based Biopharmaceutics Modelling (PBBM): What do Dissolution Scientists Need to Know?

Dissolution Technologies, 2020
Vivian A. Gray, James C. Mann, Richard Barker, Xavier J. H. Pepin   +3 more
openaire   +1 more source

Utility of Physiologically Based Biopharmaceutics Modeling (PBBM) in Regulatory Perspective: Application to Supersede f2, Enabling Biowaivers & Creation of Dissolution Safe Space

Journal of Pharmaceutical Sciences, 2022
Adithya Karthik Bhattiprolu, Sivacharan Kollipara, Tausif Ahmed   +2 more
exaly  

In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools

Pharmaceutics, 2023
Jelena Djuris, Svetlana Ibrić, Sandra Cvijic   +2 more
exaly  

Voices in Molecular Pharmaceutics: Meet Dr. Niloufar Salehi, an Enthusiastic Developer of Physiologically Based Biopharmaceutical Models

Molecular Pharmaceutics, 2023
openaire   +2 more sources

Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies

Journal of Pharmaceutical Sciences, 2019
Tycho Heimbach, Tanay S Samant
exaly  

Physiologically-Based Biopharmaceutics Modeling in Support of Drug Product Specifications and Biowaiver

Xavier Pepin, Fang Wu, Tycho Heimbach, Filippos Kesisoglou, Haritha Mandula, Rodrigo Cristofoletti, Sandra Suarez   +6 more
openaire   +1 more source

Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story

Journal of Pharmaceutical Sciences, 2018
exaly  

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 1: in vitro modeling of vericiguat

European Journal of Pharmaceutical Sciences
Maria Vertzoni, André Dallmann
exaly  

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat

European Journal of Pharmaceutical Sciences
Maria Vertzoni, André Dallmann
exaly  

A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: Paving the road towards fed state virtual BE studies for itraconazole amorphous solid dispersions

European Journal of Pharmaceutical Sciences
Rodrigo Cristofoletti
exaly